Competing interests
Diabetes
MRS, DIABETES
This study was funded by AstraZeneca. V.B.S.-H. was supported by a European Research Council starting grant (no. 759161, MRS in Diabetes). Medical writing support was provided by C. Foster, Oxford PharmaGenesis, which was funded by AstraZeneca. V.E.R.P., D.R., Y.-T.C., R.E., L.H., P.A. and L. Jermutus are employees and stockholders of AstraZeneca. E.J. is an employee of Antaros Medical. L. Johansson is an employee and stockholder of Antaros Medical. P.S. has received institutional research funding from AstraZeneca. The other authors declare no conflicts of interest.